Proton pump inhibitor leaflets: Is there information on deprescribing?
Abstract This study aims to analyze the existence of information about deprescription in the leaflets of proton pump inhibitor (PPI) medications. The leaflets available on the Brazilian Health Regulatory Agency (ANVISA) and Food and Drug Administration (FDA) websites for the following medications we...
Saved in:
Main Authors: | Marcus Vinícius Lopes Campos, Farah Maria Drumond Chequer, Luanna Gabriella Resende da Silva, André Oliveira Baldoni |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidade de São Paulo
2025-01-01
|
Series: | Brazilian Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502025000100805&lng=en&tlng=en |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deprescribing: An umbrella review
by: Japelj Nuša, et al.
Published: (2024-06-01) -
Efektivitas Media Leaflet terhadap Pengetahuan Penggunaan Obat Antihipertensi di Puskesmas Melintang
by: Aprilia Nurjanah, et al.
Published: (2022-05-01) -
Development and Validation of Patient Information Leaflet for Schizophrenia
by: C. G. Deepak, et al.
Published: (2025-01-01) -
Deprescribing and Optimal Selection of Proton Pump Inhibitors (Contributions of the 26th United Russian Gastroenterology Week)
by: V. T. Ivashkin, et al.
Published: (2020-12-01) -
The Impact of Health Promotion Using Leaflet Media on Mothers’ Knowledge of the Early Stimulation of Toddlers’ Development and Growth
by: Shalahuddin I, et al.
Published: (2025-01-01)